Publications

Utilization of oral antidiabetic medications in Taiwan following strategies to promote access to medicines for chronic diseases in community pharmacies.

J Pharm Policy Pract
Hsu JC, Ross-Degnan D, Wagner AK, Cheng CL, Yang YH, Zhang F, Lu CY

Policies and programs to facilitate access to targeted cancer therapies in Thailand.

PLoS ONE
Sruamsiri R, Ross-Degnan D, Lu CY, Chaiyakunapruk N, Wagner AK

Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand.

J Pharm Policy Pract
Lu CY, Emmerick IC, Stephens P, Ross-Degnan D, Wagner AK

Patient access schemes in Asia-pacific markets: current experience and future potential.

J Pharm Policy Pract
Lu CY, Lupton C, Rakowsky S, Babar ZU, Ross-Degnan D, Wagner AK

Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries.

Health Policy Plan
Vialle-Valentin CE, Serumaga B, Wagner AK, Ross-Degnan D

Quality use of medicines within universal health coverage: challenges and opportunities.

BMC Health Serv Res
Wagner AK, Quick JD, Ross-Degnan D

Impact of pharmaceutical policy interventions on utilization of antipsychotic medicines in Finland and Portugal in times of economic recession: interrupted time series analyses.

Int J Equity Health
Leopold C, Zhang F, Mantel-Teeuwisse AK, Vogler S, Valkova S, Ross-Degnan D, Wagner AK

Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries.

Bull. World Health Organ.
Leopold C, Mantel-Teeuwisse AK, Vogler S, Valkova S, de Joncheere K, Leufkens HG, Wagner AK, Ross-Degnan D, Laing R

Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries

Bulletin of the World Health Organization
Leopold C, Mantel-Teeuwisse AK, Vogler S, Valkova S, de Joncheere K, Leufkens H GM, Wagner AK, Ross-Degnan D, Laing R

Prescribing for acute childhood infections in developing and transitional countries, 1990-2009.

Paediatr Int Child Health
Holloway KA, Ivanovska V, Wagner AK, Vialle-Valentin C, Ross-Degnan D

Impacts of drug reimbursement reductions on utilization and expenditures of oral antidiabetic medications in Taiwan: an interrupted time series study.

Health Policy
Hsu JC, Lu CY, Wagner AK, Chan KA, Lai MS, Ross-Degnan D

Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.

Lancet Glob Health
Fang Y, Wagner AK, Yang S, Jiang M, Zhang F, Ross-Degnan D

Appointment systems are essential for improving chronic disease care in resource-poor settings: learning from experiences with HIV patients in Africa.

Int Health
Chalker JC, Wagner AK, Tomson G, Johnson K, Wahlström R, Ross-Degnan D,

Health care payments in the Asia Pacific: validation of five survey measures of economic burden.

Int J Equity Health
Reddy SR, Ross-Degnan D, Zaslavsky AM, Soumerai SB, Wagner AK

Have we improved use of medicines in developing and transitional countries and do we know how to? Two decades of evidence.

Trop. Med. Int. Health
Holloway KA, Ivanovska V, Wagner AK, Vialle-Valentin C, Ross-Degnan D

Need for and access to health care and medicines: are there gender inequities?

PLoS ONE
Wagner AK, Graves AJ, Fan Z, Walker S, Zhang F, Ross-Degnan D

Does access to medicines differ by gender? Evidence from 15 low and middle income countries.

Health Policy
Stephens P, Ross-Degnan D, Wagner AK

Changes in use of antidiabetic medications following price regulations in China (1999–2009)

J Pharm Health Serv Res
Lu CY, Ross-Degnan D, Stephens P, Liu B, Wagner AK

Improving access to medicines in low and middle income countries: corporate responsibilities in context.

South Med Rev
Leisinger KM, Garabedian LF, Wagner AK

Impact of universal health insurance coverage in Thailand on sales and market share of medicines for non-communicable diseases: an interrupted time series study.

BMJ Open
Garabedian LF, Ross-Degnan D, Ratanawijitrasin S, Stephens P, Wagner AK